IBDEI05N ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7233,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,7234,0)
 ;;=282.9^^56^551^72
 ;;^UTILITY(U,$J,358.3,7234,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7234,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,7234,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,7234,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,7235,0)
 ;;=283.19^^56^551^75
 ;;^UTILITY(U,$J,358.3,7235,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7235,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,7235,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,7235,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,7236,0)
 ;;=280.9^^56^551^79
 ;;^UTILITY(U,$J,358.3,7236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7236,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,7236,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,7236,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,7237,0)
 ;;=285.1^^56^551^77
 ;;^UTILITY(U,$J,358.3,7237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7237,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,7237,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,7237,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,7238,0)
 ;;=280.0^^56^551^78
 ;;^UTILITY(U,$J,358.3,7238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7238,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,7238,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,7238,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,7239,0)
 ;;=281.9^^56^551^99
 ;;^UTILITY(U,$J,358.3,7239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7239,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,7239,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,7239,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,7240,0)
 ;;=281.0^^56^551^119
 ;;^UTILITY(U,$J,358.3,7240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7240,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,7240,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,7240,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,7241,0)
 ;;=282.60^^56^551^106
 ;;^UTILITY(U,$J,358.3,7241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7241,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,7241,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,7241,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,7242,0)
 ;;=282.62^^56^551^107
 ;;^UTILITY(U,$J,358.3,7242,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7242,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,7242,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,7242,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,7243,0)
 ;;=281.1^^56^551^120
 ;;^UTILITY(U,$J,358.3,7243,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7243,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,7243,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,7243,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,7244,0)
 ;;=286.7^^56^551^47
 ;;^UTILITY(U,$J,358.3,7244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7244,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,7244,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,7244,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,7245,0)
 ;;=289.9^^56^551^115
 ;;^UTILITY(U,$J,358.3,7245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7245,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,7245,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,7245,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,7246,0)
 ;;=451.9^^56^551^116
 ;;^UTILITY(U,$J,358.3,7246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7246,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,7246,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,7246,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,7247,0)
 ;;=446.6^^56^551^117
 ;;^UTILITY(U,$J,358.3,7247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7247,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,7247,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,7247,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,7248,0)
 ;;=286.4^^56^551^121
 ;;^UTILITY(U,$J,358.3,7248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7248,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,7248,1,5,0)
 ;;=5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,7248,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,7249,0)
 ;;=204.00^^56^551^4
 ;;^UTILITY(U,$J,358.3,7249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7249,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,7249,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,7249,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,7250,0)
 ;;=204.01^^56^551^3
 ;;^UTILITY(U,$J,358.3,7250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7250,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,7250,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,7250,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,7251,0)
 ;;=204.10^^56^551^43
 ;;^UTILITY(U,$J,358.3,7251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7251,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,7251,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,7251,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,7252,0)
 ;;=204.11^^56^551^42
 ;;^UTILITY(U,$J,358.3,7252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7252,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,7252,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,7252,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,7253,0)
 ;;=201.90^^56^551^76
 ;;^UTILITY(U,$J,358.3,7253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7253,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,7253,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,7253,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,7254,0)
 ;;=785.6^^56^551^83
 ;;^UTILITY(U,$J,358.3,7254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7254,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,7254,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,7254,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,7255,0)
 ;;=200.20^^56^551^85
 ;;^UTILITY(U,$J,358.3,7255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7255,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,7255,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,7255,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,7256,0)
 ;;=202.00^^56^551^87
 ;;^UTILITY(U,$J,358.3,7256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7256,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,7256,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,7256,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,7257,0)
 ;;=200.10^^56^551^86
 ;;^UTILITY(U,$J,358.3,7257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7257,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,7257,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,7257,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,7258,0)
 ;;=273.3^^56^551^88
 ;;^UTILITY(U,$J,358.3,7258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7258,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,7258,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,7258,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,7259,0)
 ;;=203.00^^56^551^97
 ;;^UTILITY(U,$J,358.3,7259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7259,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,7259,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,7259,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,7260,0)
 ;;=203.01^^56^551^96
 ;;^UTILITY(U,$J,358.3,7260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7260,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,7260,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,7260,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,7261,0)
 ;;=238.6^^56^551^100
 ;;^UTILITY(U,$J,358.3,7261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7261,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,7261,1,5,0)
 ;;=5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,7261,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,7262,0)
 ;;=205.00^^56^551^6
 ;;^UTILITY(U,$J,358.3,7262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7262,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,7262,1,5,0)
 ;;=5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,7262,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,7263,0)
 ;;=205.01^^56^551^5
 ;;^UTILITY(U,$J,358.3,7263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7263,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,7263,1,5,0)
 ;;=5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,7263,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,7264,0)
 ;;=205.10^^56^551^45
 ;;^UTILITY(U,$J,358.3,7264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7264,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,7264,1,5,0)
 ;;=5^Cml, W/O Remission
 ;;^UTILITY(U,$J,358.3,7264,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,7265,0)
 ;;=205.11^^56^551^44
 ;;^UTILITY(U,$J,358.3,7265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7265,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,7265,1,5,0)
 ;;=5^Cml, In Remission
 ;;^UTILITY(U,$J,358.3,7265,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,7266,0)
 ;;=289.0^^56^551^49
 ;;^UTILITY(U,$J,358.3,7266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7266,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,7266,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,7266,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,7267,0)
 ;;=238.4^^56^551^101
 ;;^UTILITY(U,$J,358.3,7267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7267,1,4,0)
 ;;=4^238.4
 ;;^UTILITY(U,$J,358.3,7267,1,5,0)
 ;;=5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,7267,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,7268,0)
 ;;=V58.61^^56^551^122
 ;;^UTILITY(U,$J,358.3,7268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7268,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,7268,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,7268,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,7269,0)
 ;;=282.49^^56^551^111
 ;;^UTILITY(U,$J,358.3,7269,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7269,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,7269,1,5,0)
 ;;=5^Thalassemia Nec
 ;;^UTILITY(U,$J,358.3,7269,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,7270,0)
 ;;=289.89^^56^551^15
 ;;^UTILITY(U,$J,358.3,7270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7270,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,7270,1,5,0)
 ;;=5^Blood Diseases Nec
 ;;^UTILITY(U,$J,358.3,7270,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,7271,0)
 ;;=238.79^^56^551^82
 ;;^UTILITY(U,$J,358.3,7271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7271,1,4,0)
 ;;=4^238.79
